Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Drug Overdose to Toxicology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Drug Overdose to Toxicology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Drug Overdose Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Source 64

List of Tables
Drug Overdose Therapeutics, Global, Clinical Trials by Region, 2017* 7
Drug Overdose Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Drug Overdose Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Drug Overdose Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11
Drug Overdose Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Drug Overdose Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Drug Overdose Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Proportion of Drug Overdose to Toxicology Clinical Trials, G7 Countries (%), 2017* 15
Drug Overdose Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Drug Overdose Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Drug Overdose to Toxicology Clinical Trials, E7 Countries (%), 2017* 18
Drug Overdose Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Drug Overdose Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Drug Overdose Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Drug Overdose Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Drug Overdose Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Drug Overdose Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Drug Overdose Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Drug Overdose Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Drug Overdose Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Drug Overdose Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Drug Overdose Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures
Drug Overdose Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Drug Overdose Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Drug Overdose Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Drug Overdose Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 11
Drug Overdose Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Drug Overdose Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
Proportion of Drug Overdose to Toxicology Clinical Trials, G7 Countries (%), 2017* 15
Drug Overdose Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Drug Overdose Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Drug Overdose to Toxicology Clinical Trials, E7 Countries (%), 2017* 18
Drug Overdose Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Drug Overdose Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Drug Overdose Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Drug Overdose Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Drug Overdose Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Drug Overdose Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Drug Overdose Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Drug Overdose Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Drug Overdose Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Drug Overdose Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Drug Overdose Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
GlobalData Methodology 63

Companies Mentioned
- Insys Therapeutics Inc
- BTG Plc
- kaleo Inc
- Cumberland Pharmaceuticals Inc
- Core Human Factors Inc
- AS The Norwegian Ether Factory
- Arbor Pharmaceuticals LLC
- Aoxing Pharmaceutical Company Inc
- Altasciences Company Inc
- Adapt Pharma Ltd